1500 related articles for article (PubMed ID: 17388667)
1. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men.
Wang L; Ma J; Manson JE; Buring JE; Gaziano JM; Sesso HD
Eur J Nutr; 2013 Oct; 52(7):1771-9. PubMed ID: 23262750
[TBL] [Abstract][Full Text] [Related]
4. VDR FokI polymorphism is associated with a reduced T-helper cell population under vitamin D stimulation in type 1 diabetes patients.
Morán-Auth Y; Penna-Martinez M; Badenhoop K
J Steroid Biochem Mol Biol; 2015 Apr; 148():184-6. PubMed ID: 25576905
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
Xu Y; Shibata A; McNeal JE; Stamey TA; Feldman D; Peehl DM
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):23-7. PubMed ID: 12540499
[TBL] [Abstract][Full Text] [Related]
6. Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy.
Huang SP; Huang CY; Wu WJ; Pu YS; Chen J; Chen YY; Yu CC; Wu TT; Wang JS; Lee YH; Huang JK; Huang CH; Wu MT
Int J Cancer; 2006 Oct; 119(8):1902-7. PubMed ID: 16708371
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.
Mikhak B; Hunter DJ; Spiegelman D; Platz EA; Hollis BW; Giovannucci E
Prostate; 2007 Jun; 67(9):911-23. PubMed ID: 17440943
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
[TBL] [Abstract][Full Text] [Related]
9. The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.
Baykan O; Akgul M; Uren N; Yaman A; Tinay I; Ergul E; Sazci A; Turkeri L; Haklar G
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969078
[TBL] [Abstract][Full Text] [Related]
10. The Fok1 vitamin D receptor gene polymorphism and 25(OH) D serum levels and prostate cancer among Jordanian men.
Atoum MF; AlKateeb D; AlHaj Mahmoud SA
Asian Pac J Cancer Prev; 2015; 16(6):2227-30. PubMed ID: 25824742
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor polymorphisms in differentiated thyroid carcinoma.
Penna-Martinez M; Ramos-Lopez E; Stern J; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Vorländer C; Wahl RA; Bechstein WO; Zeuzem S; Holzer K; Badenhoop K
Thyroid; 2009 Jun; 19(6):623-8. PubMed ID: 19499989
[TBL] [Abstract][Full Text] [Related]
12. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
McKay JD; McCullough ML; Ziegler RG; Kraft P; Saltzman BS; Riboli E; Barricarte A; Berg CD; Bergland G; Bingham S; Brustad M; Bueno-de-Mesquita HB; Burdette L; Buring J; Calle EE; Chanock SJ; Clavel-Chapelon F; Cox DG; Dossus L; Feigelson HS; Haiman CA; Hankinson SE; Hoover RN; Hunter DJ; Husing A; Kaaks R; Kolonel LN; Le Marchand L; Linseisen J; McCarty CA; Overvad K; Panico S; Purdue MP; Stram DO; Stevens VL; Trichopoulos D; Willett WC; Yuenger J; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):297-305. PubMed ID: 19124512
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.
Hendrickson WK; Flavin R; Kasperzyk JL; Fiorentino M; Fang F; Lis R; Fiore C; Penney KL; Ma J; Kantoff PW; Stampfer MJ; Loda M; Mucci LA; Giovannucci E
J Clin Oncol; 2011 Jun; 29(17):2378-85. PubMed ID: 21537045
[TBL] [Abstract][Full Text] [Related]
16. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.
Peters U; Hayes RB; Chatterjee N; Shao W; Schoen RE; Pinsky P; Hollis BW; McGlynn KA;
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):546-52. PubMed ID: 15066918
[TBL] [Abstract][Full Text] [Related]
17. Association of FokI polymorphism of vitamin D receptor with urothelial bladder cancer in Tunisians: role of tobacco smoking and plasma vitamin D concentration.
Ben Fradj MK; Kallel A; Gargouri MM; Chehida MA; Sallemi A; Ouanes Y; Rhouma SB; Riadh J; Feki M; Nouira Y; Kaabachi N
Tumour Biol; 2016 May; 37(5):6197-203. PubMed ID: 26615419
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor gene FokI polymorphism in Egyptian children and adolescents with SLE: A case-control study.
Imam AA; Ibrahim HE; Farghaly MAA; Alkholy UM; Gawish HH; Abdalmonem N; Sherif AM; Ali YF; Hamed ME; Waked NM; Fathy MM; Khalil AM; Noah MA; Hegab MS; Ibrahim BR; Nabil RM; Fattah LA
Lupus; 2017 Nov; 26(13):1426-1434. PubMed ID: 28799838
[TBL] [Abstract][Full Text] [Related]
19. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
[TBL] [Abstract][Full Text] [Related]
20. Effects of Fok-I polymorphism in vitamin D receptor gene on serum 25-hydroxyvitamin D, bone-specific alkaline phosphatase and calcaneal quantitative ultrasound parameters in young adults.
Tanabe R; Kawamura Y; Tsugawa N; Haraikawa M; Sogabe N; Okano T; Hosoi T; Goseki-Sone M
Asia Pac J Clin Nutr; 2015; 24(2):329-35. PubMed ID: 26078251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
